🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

30 results for “VYNE” Clear

  1. 5 mg Serlopitant Tablets

    VYNE Therapeutics

    Pruritus

    phase 3 small molecule terminated

    3 trials

  2. 5mg Serlopitant Tablets

    VYNE Therapeutics

    Pruritus

    phase 3 small molecule completed

    2 trials

  3. FMX-101, 4% minocycline foam

    VYNE Therapeutics

    Acne Vulgaris

    phase 3 small molecule completed

    2 trials

  4. FMX101

    VYNE Therapeutics

    Acne Vulgaris

    phase 3 small molecule completed

    1 trial

  5. FMX103 1.5%

    VYNE Therapeutics

    Papulopustular Rosacea

    phase 3 small molecule completed

    1 trial

  6. FMX103 minocycline foam 1.5%

    VYNE Therapeutics

    Facial Papulopustular Rosacea

    phase 3 small molecule completed

    2 trials

  7. 5 mg Serlopitant Tablets

    VYNE Therapeutics

    Refractory Chronic Cough

    phase 2 small molecule completed

    1 trial

  8. ARK-E021 5%

    VYNE Therapeutics

    Acne Vulgaris

    phase 2 small molecule completed

    1 trial

  9. Comparator: MK0594 5 mg/day

    VYNE Therapeutics

    Alcohol Dependence

    phase 2 small molecule terminated

    1 trial

  10. FCD105

    VYNE Therapeutics

    Acne Vulgaris

    phase 2 other completed

    1 trial

  11. FDX104 (4% Doxycycline)

    VYNE Therapeutics

    Rash Due to Epidermal Growth Factor Receptor Inhibitors

    phase 2 small molecule completed

    1 trial

  12. FMX-103 1.5%

    VYNE Therapeutics

    Rosacea

    phase 2 small molecule completed

    1 trial

  13. FMX114

    VYNE Therapeutics

    Atopic Dermatitis

    phase 2 small molecule completed

    1 trial

  14. MK0594

    VYNE Therapeutics

    Urinary Incontinence

    phase 2 small molecule completed

    1 trial

  15. Permethrin Foam 4%

    VYNE Therapeutics

    Scabies

    phase 2 small molecule completed

    1 trial

  16. Serlopitant

    VYNE Therapeutics

    Pruritus

    phase 2 small molecule terminated

    1 trial

  17. Serlopitant High Dose

    VYNE Therapeutics

    Pruritus

    phase 2 small molecule completed

    1 trial

  18. Serlopitant Tablet

    VYNE Therapeutics

    Epidermolysis Bullosa

    phase 2 small molecule completed

    1 trial

  19. Topical Minocycline Foam FXFM244

    VYNE Therapeutics

    Rosacea

    phase 2 small molecule terminated

    1 trial

  20. Topical Minocycline Foam FXFM244

    VYNE Therapeutics

    Impetigo

    phase 2 small molecule completed

    1 trial

  21. Topical Minocycline Foam FXFM244

    VYNE Therapeutics

    Acne Vulgaris

    phase 2 small molecule completed

    1 trial

  22. VPD-737

    VYNE Therapeutics

    Chronic Pruritus

    phase 2 small molecule completed

    1 trial

  23. VPD-737

    VYNE Therapeutics

    Epidermolysis Bullosa

    phase 2 small molecule completed

    1 trial

  24. VYN201 Gel

    VYNE Therapeutics

    Non-segmental Vitiligo

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources